OXFD - Oxford Immunotec Global PLC

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue59,75354,73346,98862,782
Cost of Revenue16,82618,47016,49129,544
Gross Profit42,92736,26330,49733,238
Operating Expenses
Research Development5,8229,0668,2709,481
Selling General and Administrative54,75256,09045,74647,312
Non Recurring----
Others----
Total Operating Expenses77,40083,62670,50786,337
Operating Income or Loss-17,647-28,893-23,519-23,555
Income from Continuing Operations
Total Other Income/Expenses Net-7,134-2,699-1,833-777
Earnings Before Interest and Taxes-17,647-28,893-23,519-23,555
Interest Expense-1,797-3,105-864-67
Income Before Tax-24,781-31,592-25,352-24,332
Income Tax Expense-37,2861,634-3,774146
Minority Interest----
Net Income From Continuing Ops12,505-33,226-21,578-24,478
Non-recurring Events
Discontinued Operations108,274341-771-771
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income120,779-32,885-22,349-24,478
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares120,779-32,885-22,349-24,478